Transcriptional regulation of Wnt inhibitory factor-1 by Miz-1/c-Myc

Oncogene

Volumn 29, Issue 44, 2010, Pages 5923-5934

  Licchesi, J D F ^a,b   Van Neste, L ^c   Tiwari, V K ^a   Cope, L ^a   Lin, X ^d   Baylin, S B ^a   Herman, J G ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^c GHENT UNIVERSITY   (Belgium)

^d Johns Hopkins University   (United States)

Author keywords

c Myc; DNA methylation; Miz 1; WIF 1; Wnt signaling

Indexed keywords

DNA; MIZ 1 PROTEIN; MYC PROTEIN; UNCLASSIFIED DRUG; WNT INHIBITORY FACTOR 1 PROTEIN; WNT PROTEIN;

ARTICLE; CELL LINE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE MAPPING; GENE OVEREXPRESSION; GENE SILENCING; GENETIC SCREENING; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 78149470757     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.322     Document Type: Article

References (52)

1. Ahmed AA, Mills AD, Ibrahim AE, Temple J, Blenkiron C, Vias M et al. (2007). The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel. Cancer Cell 12: 514-527.
2. Ai L, Tao Q, Zhong S, Fields CR, Kim WJ, Lee MW et al. (2006). Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer. Carcino-genesis 27: 1341-1348.
3. Barr LF, Campbell SE, Diette GB, Gabrielson EW, Kim S, Shim H et al. (2000). c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression. Cancer Res 60: 143-149.
4. Benanti JA, Wang ML, Myers HE, Robinson KL, Grandori C, Galloway DA. (2007). Epigenetic down-regulation of ARF expression is a selection step in immortalization of human fibroblasts by c-Myc. Mol Cancer Res 5: 1181-1189.
5. Bowen H, Biggs TE, Phillips E, Baker ST, Perry VH, Mann DA et al. (2002). c-Myc represses and Miz-1 activates the murine natural resistance-associated protein 1 promoter. J Biol Chem 277: 34997-35006.
6. Brenner C, Deplus R, Didelot C, Loriot A, Vire E, De Smet C et al. (2005). Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J 24: 336-346.
7. Bush A, Mateyak M, Dugan K, Obaya A, Adachi S, Sedivy J et al. (1998). c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets. Genes Dev 12: 3797-3802.
8. Chan SL, Cui Y, van Hasselt A, Li H, Srivastava G, Jin H et al. (2007). The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas. Lab Invest 87: 644-650.
9. Chen ZX, Mann JR, Hsieh CL, Riggs AD, Chedin F. (2005). Physical and functional interactions between the human DNMT3L protein and members of the de novo methyltransferase family. J Cell Biochem 95: 902-917.
10. Cowling VH, D'Cruz CM, Chodosh LA, Cole MD. (2007). c-Myc transforms human mammary epithelial cells through repression of the Wnt Inhibitors DKK1 and SFRP1. Mol Cell Biol 27: 5135-5146.
11. de la Roche M, Worm J, Bienz M. (2008). The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells. BMC Cancer 8: 199.
12. Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M et al. (2002). Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295: 1079-1082.
13. Finlan LE, Sproul D, Thomson I, Boyle S, Kerr E, Perry P et al. (2008). Recruitment to the nuclear periphery can alter expression of genes in human cells. PLoS Genet 4: e1000039.
14. Gartel AL, Ye X, Goufman E, Shianov P, Hay N, Najmabadi F et al. (2001). Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc Natl Acad Sci USA 98: 4510-4515.
15. Gebhardt A, Frye M, Herold S, Benitah SA, Braun K, Samans B et al. (2006). Myc regulates keratinocyte adhesion and differentiation via complex formation with Miz1. J Cell Biol 172: 139-149.
16. Guarda A, Bolognese F, Bonapace IM, Badaracco G. (2009). Interaction between the inner nuclear membrane lamin b receptor and the heterochromatic methyl binding protein, MeCP2. Exp Cell Res 315: 18903.
17. Gujral TS, MacBeath G. (2009). Emerging miniaturized proteomic technologies to study cell signaling in clinical samples. Sci Signal 2: pe65.
18. Halaban R, Krauthammer M, Pelizzola M, Cheng E, Kovacs D, Sznol M et al. (2009). Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications. PloS One 4: e4563.
19. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT et al. (1998). Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
20. Herman JG, Baylin SB. (2003). Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349: 2042-2054.
21. Hsieh JC, Kodjabachian L, Rebbert ML, Rattner A, Smallwood PM, Samos CH et al. (1999). A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 398: 431-436.
22. Ikegaki N, Gotoh T, Kung B, Riceberg JS, Kim DY, Zhao H et al. (2007). De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblas-toma gene. Clin Cancer Res 13: 6001-6009.
23. Li H, Rauch T, Chen ZX, Szabo PE, Riggs AD, Pfeifer GP. (2006). The histone methyltransferase SETDB1 and the DNA methyl-transferase DNMT3A interact directly and localize to promoters silenced in cancer cells. J Biol Chem 281: 19489-19500.
24. Li Z, Luo RT, Mi S, Sun M, Chen P, Bao J et al. (2009). Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias. Cancer Res 69: 1109-1116.
25. Licchesi JD, Westra WH, Hooker CM, Machida EO, Baylin SB, Herman JG. (2008). Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung. Carcinogenesis 29: 895-904.
26. Liu X, Mazanek P, Dam V, Wang Q, Zhao H, Guo R et al. (2008). Deregulated Wnt/beta-catenin program in high-risk neuroblastomas without MYCN amplification. Oncogene 27: 1478-1488.
27. Mazieres J, He B, You L, Xu Z, Lee AY, Mikami I et al. (2004). Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res 64: 4717-4720. (Pubitemid 38924512)
28. McGarvey KM, Fahrner JA, Greene E, Martens J, Jenuwein T, Baylin SB. (2006). Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state. Cancer Res 66: 3541-3549.
29. Osborne CS, Chakalova L, Mitchell JA, Horton A, Wood AL, Bolland DJ et al. (2007). Myc dynamically and preferentially relocates to a transcription factory occupied by Igh. PLoS Biol 5: e192.
30. Patel JH, McMahon SB. (2006). Targeting of Miz-1 is essential for Myc-mediated apoptosis. J Biol Chem 281: 3283-3289.
31. Patel JH, McMahon SB. (2007). BCL2 is a downstream effector of MIZ-1 essential for blocking c-MYC-induced apoptosis. J Biol Chem 282: 5-13.
32. Perini G, Diolaiti D, Porro A, Della Valle G. (2005). In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation. Proc Natl Acad Sci USA 102: 12117-12122.
33. Peukert K, Staller P, Schneider A, Carmichael G, Hanel F, Eilers M. (1997). An alternative pathway for gene regulation by Myc. EMBO J 16: 5672-5686.
34. Reguart N, He B, Xu Z, You L, Lee AY, Mazieres J et al. (2004). Cloning and characterization of the promoter of human Wnt inhibitory factor-1. Biochem Biophys Res Commun 323: 229-234. (Pubitemid 39200673)
35. Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE et al. (2002). DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416: 552-556.
36. Rountree MR, Bachman KE, Baylin SB. (2000). DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat Genet 25: 269-277.
37. Schuebel KE, Chen W, Cope L, Glockner SC, Suzuki H, Yi JM et al. (2007). Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 3: 1709-1723.
38. Seoane J, Pouponnot C, Staller P, Schader M, Eilers M, Massague J. (2001). TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat Cell Biol 3: 400-408.
39. Seoane J, Le HV, Massague J. (2002). Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419: 729-734.
40. Shah JN, Shao G, Hei TK, Zhao Y. (2008). Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR. BMC Cancer 8: 284.
41. Smale ST, Baltimore D. (1989). The 'initiator' as a transcription control element. Cell 57: 103-113.
42. Staller P, Peukert K, Kiermaier A, Seoane J, Lukas J, Karsunky H et al. (2001). Repression of p15INK4b expression by Myc through association with Miz-1. Nat Cell Biol 3: 392-399.
43. Tang Y, Simoneau AR, Liao WX, Yi G, Hope C, Liu F et al. (2009). WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells. Mol Cancer Ther 8: 458-468.
44. Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K et al. (2005). Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers. Oncogene 24: 7946-7952.
45. Tiwari VK, McGarvey KM, Licchesi JD, Ohm JE, Herman JG, Schubeler D et al. (2008). PcG proteins, DNA methylation, and gene repression by chromatin looping. PLoS Biol 6: 2911-2927.
46. Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T et al. (2006). Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res 12: 383-391.
47. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A et al. (2002). The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111: 241-250.
48. Villa R, Pasini D, Gutierrez A, Morey L, Occhionorelli M, Vire E et al. (2007). Role of the polycomb repressive complex 2 in acute promyelocytic leukemia. Cancer Cell 11: 513-525.
49. Wu S, Cetinkaya C, Munoz-Alonso MJ, von der Lehr N, Bahram F, Beuger V et al. (2003). Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 22: 351-360.
50. Yu L, Liu C, Vandeusen J, Becknell B, Dai Z, Wu YZ et al. (2005). Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nat Genet 37: 265-274.
51. Zhang Y, Wen G, Shao G, Wang C, Lin C, Fang H et al. (2009). TGFBI deficiency predisposes mice to spontaneous tumor development. Cancer Res 69: 37-44.
52. Zinn RL, Pruitt K, Eguchi S, Baylin SB, Herman JG. (2007). hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res 67: 194-201.